Radiotherapy - Global Market Outlook (2016-2022)

  • ID: 4335754
  • Report
  • Region: Global
  • Stratistics Market Research Consulting Pvt Ltd
1 of 4

FEATURED COMPANIES

  • Accuray Inc
  • Brainlab AG
  • CIVCO Medical Solutions
  • Elekta AB
  • IBA Group
  • IsoRay Medical, Inc.
  • MORE

The Global Radiotherapy Market is expected to reach $10.2 billion by 2022 growing at a CAGR of 6.6% during the forecast period. Rising number of cancer patients, technological advancements and increasing aging population are some of the key factors fueling the market growth. However, lack of sufficient infrastructure and healthcare costs are expected to hinder the market.

Technologies such as External beam radiotherapy and internal beam radiotherapy are anticipated to witness highest growth owing to increased pool of cancer patients. North America commanded the largest market share as it is constantly inclined to the newer technologies when compared to slow-moving markets such as Europe. Rising incidence of cancer and unmet healthcare needs in APAC provides ample of opportunities for the players in the market over the foreseeable future.

Some of the key players in the market include Siemens Healthcare, GE Healthcare, Nordion, Inc., IBA Group, Angiodynamics Inc, Ion Beam Applications SA, Protom International Inc, IsoRay Medical, Inc., Coviden Plc, Varian Medical Systems Inc, Accuray Inc, Mevion Medical Systems, Inc, C.R. BARD Inc, CIVCO Medical Solutions, Mitsubishi Electric Corporation, Brainlab AG, RaySearch Laboratories AB, Elekta AB and Nanobiotix.

Equipments Covered:

  • Linear Accelerators
    • Treatment Planning Systems
    • Radiation Therapy Simulators

Technologies Covered:

  • Internal radiation therapy
    • High Dose Rate Radiotherapy
    • Low-Dose Rate Radiotherapy
  • Systemic radiation therapy
  • External Beam Radiation Therapy
    • Stereotactic body radiation therapy
    • Intensity-modulated radiation therapy (IMRT)
    • 3D-Conformal Radiotherapy (3D-CRT)
    • Tomotherapy
    • Volumetric Modulated ARC Therapy
    • Image-guided radiation therapy (IGRT)
    • Proton Beam therapy
    • Stereotactic radiosurgery

Product Types Covered:

  • Electron Beams
  • Non-Ionizing Radiation
  • Photon Radiations
  • Ionizing Radiation
  • Alpha and Beta Particles
  • Particle Radiation
  • Neutron Beams
  • Gamma Rays
  • X-rays
  • Proton Beams
  • Carbon Ions

Applications Covered:

  • Head and Neck Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Spine Cancer
  • Cervical Cancer
  • Penile Cancer
  • Gynaecological Cancer
  • Skin & Lip Cancer
  • Lung Cancer
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • Rest of the World
    • Middle East
    • Brazil
    • Argentina
    • South Africa
    • Egypt

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Accuray Inc
  • Brainlab AG
  • CIVCO Medical Solutions
  • Elekta AB
  • IBA Group
  • IsoRay Medical, Inc.
  • MORE

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Product Analysis
3.8 Application Analysis
3.9 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Radiotherapy Market, By Equipment
5.1 Introduction
5.2 Linear Accelerators
5.2.1 Treatment Planning Systems
5.2.2 Radiation Therapy Simulators

6 Global Radiotherapy Market, By Technology
6.1 Introduction
6.2 Internal radiation therapy
6.2.1 High Dose Rate Radiotherapy
6.2.2 Low-Dose Rate Radiotherapy
6.3 Systemic radiation therapy
6.4 External Beam Radiation Therapy
6.4.1 Stereotactic body radiation therapy
6.4.2 Intensity-modulated radiation therapy (IMRT)
6.4.3 3D-Conformal Radiotherapy (3D-CRT)
6.4.4 Tomotherapy
6.4.5 Volumetric Modulated ARC Therapy
6.4.6 Image-guided radiation therapy (IGRT)
6.4.7 Proton Beam therapy
6.4.8 Stereotactic radiosurgery

7 Global Radiotherapy Market, By Product Type
7.1 Introduction
7.2 Electron Beams
7.3 Non-Ionizing Radiation
7.4 Photon Radiations
7.5 Ionizing Radiation
7.6 Alpha and Beta Particles
7.7 Particle Radiation
7.8 Neutron Beams
7.9 Gamma Rays
7.10 X-rays
7.11 Proton Beams
7.12 Carbon Ions

8 Global Radiotherapy Market, By Application
8.1 Introduction
8.2 Head and Neck Cancer
8.3 Breast Cancer
8.4 Prostate Cancer
8.5 Colorectal Cancer
8.6 Spine Cancer
8.7 Cervical Cancer
8.8 Penile Cancer
8.9 Gynaecological Cancer
8.10 Skin & Lip Cancer
8.11 Lung Cancer
8.12 Other Applications

9 Global Radiotherapy Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Siemens Healthcare
11.2 GE Healthcare
11.3 Nordion, Inc.
11.4 IBA Group
11.5 Angiodynamics Inc
11.6 Ion Beam Applications SA
11.7 Protom International Inc
11.8 IsoRay Medical, Inc.
11.9 Coviden Plc
11.10 Varian Medical Systems Inc
11.11 Accuray Inc
11.12 Mevion Medical Systems, Inc
11.13 C.R. BARD Inc
11.14 CIVCO Medical Solutions
11.15 Mitsubishi Electric Corporation
11.16 Brainlab AG
11.17 RaySearch Laboratories AB
11.18 Elekta AB
11.19 Nanobiotix

List of Tables
1 Global Radiotherapy Market Outlook, By Region (2013-2022) ($MN)
2 Global Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
3 Global Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
4 Global Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
5 Global Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
6 Global Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
7 Global Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
8 Global Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
9 Global Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
10 Global Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
11 Global Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
12 Global Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
13 Global Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
14 Global Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
15 Global Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
16 Global Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
17 Global Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
18 Global Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
19 Global Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
20 Global Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
21 Global Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
22 Global Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
23 Global Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
24 Global Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
25 Global Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
26 Global Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
27 Global Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
28 Global Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
29 Global Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
30 Global Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
31 Global Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
32 Global Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
33 Global Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
34 Global Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
35 Global Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
36 Global Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
37 Global Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
38 Global Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
39 Global Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
40 Global Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
41 Global Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
42 Global Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
43 Global Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)
44 North America Radiotherapy Market Outlook, By Country (2013-2022) ($MN)
45 North America Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
46 North America Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
47 North America Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
48 North America Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
49 North America Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
50 North America Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
51 North America Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
52 North America Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
53 North America Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
54 North America Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
55 North America Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
56 North America Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
57 North America Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
58 North America Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
59 North America Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
60 North America Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
61 North America Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
62 North America Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
63 North America Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
64 North America Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
65 North America Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
66 North America Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
67 North America Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
68 North America Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
69 North America Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
70 North America Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
71 North America Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
72 North America Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
73 North America Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
74 North America Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
75 North America Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
76 North America Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
77 North America Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
78 North America Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
79 North America Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
80 North America Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
81 North America Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
82 North America Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
83 North America Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
84 North America Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
85 North America Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
86 North America Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)
87 Europe Radiotherapy Market Outlook, By Country (2013-2022) ($MN)
88 Europe Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
89 Europe Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
90 Europe Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
91 Europe Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
92 Europe Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
93 Europe Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
94 Europe Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
95 Europe Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
96 Europe Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
97 Europe Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
98 Europe Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
99 Europe Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
100 Europe Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
101 Europe Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
102 Europe Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
103 Europe Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
104 Europe Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
105 Europe Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
106 Europe Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
107 Europe Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
108 Europe Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
109 Europe Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
110 Europe Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
111 Europe Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
112 Europe Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
113 Europe Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
114 Europe Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
115 Europe Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
116 Europe Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
117 Europe Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
118 Europe Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
119 Europe Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
120 Europe Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
121 Europe Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
122 Europe Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
123 Europe Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
124 Europe Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
125 Europe Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
126 Europe Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
127 Europe Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
128 Europe Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
129 Europe Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)
130 Asia Pacific Radiotherapy Market Outlook, By Country (2013-2022) ($MN)
131 Asia Pacific Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
132 Asia Pacific Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
133 Asia Pacific Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
134 Asia Pacific Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
135 Asia Pacific Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
136 Asia Pacific Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
137 Asia Pacific Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
138 Asia Pacific Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
139 Asia Pacific Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
140 Asia Pacific Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
141 Asia Pacific Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
142 Asia Pacific Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
143 Asia Pacific Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
144 Asia Pacific Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
145 Asia Pacific Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
146 Asia Pacific Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
147 Asia Pacific Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
148 Asia Pacific Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
149 Asia Pacific Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
150 Asia Pacific Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
151 Asia Pacific Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
152 Asia Pacific Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
153 Asia Pacific Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
154 Asia Pacific Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
155 Asia Pacific Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
156 Asia Pacific Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
157 Asia Pacific Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
158 Asia Pacific Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
159 Asia Pacific Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
160 Asia Pacific Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
161 Asia Pacific Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
162 Asia Pacific Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
163 Asia Pacific Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
164 Asia Pacific Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
165 Asia Pacific Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
166 Asia Pacific Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
167 Asia Pacific Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
168 Asia Pacific Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
169 Asia Pacific Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
170 Asia Pacific Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
171 Asia Pacific Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
172 Asia Pacific Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)
173 Rest of the World Radiotherapy Market Outlook, By Country (2013-2022) ($MN)
174 Rest of the World Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
175 Rest of the World Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
176 Rest of the World Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
177 Rest of the World Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
178 Rest of the World Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
179 Rest of the World Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
180 Rest of the World Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
181 Rest of the World Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
182 Rest of the World Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
183 Rest of the World Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
184 Rest of the World Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
185 Rest of the World Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
186 Rest of the World Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
187 Rest of the World Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
188 Rest of the World Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
189 Rest of the World Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
190 Rest of the World Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
191 Rest of the World Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
192 Rest of the World Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
193 Rest of the World Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
194 Rest of the World Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
195 Rest of the World Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
196 Rest of the World Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
197 Rest of the World Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
198 Rest of the World Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
199 Rest of the World Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
200 Rest of the World Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
201 Rest of the World Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
202 Rest of the World Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
203 Rest of the World Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
204 Rest of the World Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
205 Rest of the World Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
206 Rest of the World Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
207 Rest of the World Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
208 Rest of the World Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
209 Rest of the World Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
210 Rest of the World Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
211 Rest of the World Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
212 Rest of the World Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
213 Rest of the World Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
214 Rest of the World Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
215 Rest of the World Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Accuray Inc
  • Angiodynamics Inc
  • Brainlab AG
  • C.R. BARD Inc
  • CIVCO Medical Solutions
  • Coviden Plc
  • Elekta AB
  • GE Healthcare
  • IBA Group
  • Ion Beam Applications SA
  • IsoRay Medical, Inc.
  • Mevion Medical Systems, Inc
  • Mitsubishi Electric Corporation
  • Nanobiotix
  • Nordion, Inc.
  • Protom International Inc
  • RaySearch Laboratories AB
  • Siemens Healthcare
  • Varian Medical Systems Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll